Signal active
Organization
Contact Information
Overview
Remedy is a prescriptive chronic care analytics platform employing artificial intelligence to help value-based health systems determine who should get what care, when, how, and by whom to maximize patient health outcomes per dollar spent. We are a design-driven company with core medical AI technology capable of diagnosing disease, catching hidden high-risk diagnoses, and projecting the development of patient’s health into the future. Built around our core AI engine, our first product Remedy Sentinel helps value-based providers identify hidden chronic, co-morbid conditions and intervene by engaging high-risk patients prior to onset. We envision a world where healthcare marries the science of “health” with the art of “care”: scientific, data-driven decision making drives the best outcomes for each individual patient, and frees providers to focus on applying their human touch.
Remedy combines novel artificial intelligence algorithms for predictive medical analytics with a healthcare-optimized product development process to give leaders the tools they need to transform their delivery networks and thrive in a value-based care environment. With this approach, Remedy builds a scalable suite of products that, when deployed, learn from experience, and grow into a solution optimized to fit the needs of specific provider groups and the populations they serve.
Remedy systematically maximizes the patient health outcome achieved with each dollar spent by using AI to help determine what care is delivered to whom, when it is delivered, where it is delivered, how it is delivered, followed, and supported, and who should deliver it. We not only surface insights, but also build the necessary tools and helps coordinate step-by-step implementation processes to affect real change.
About
Artificial Intelligence (AI), Health Care, Personal Health, Home Health Care
2016
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Remedy headquartered in United States, North America, operates in the Artificial Intelligence (AI), Health Care, Personal Health, Home Health Care sector. With a team of 1-10 employees, Remedy is actively contributing to advancements in Artificial Intelligence (AI). Their latest funding round, Seed Round - Remedy, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
1
6
0
$0
Details
1
Remedy has raised a total of $0 in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2018 | Seed |
Investors
Remedy is funded by 6 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Princeton Alumni Entrepreneurs Fund | - | FUNDING ROUND - Princeton Alumni Entrepreneurs Fund | undefined |
Jeff Dean | - | FUNDING ROUND - Jeff Dean | undefined |
Remedy | - | FUNDING ROUND - Remedy | undefined |
Mark Attanasio | - | FUNDING ROUND - Mark Attanasio | undefined |
Recent Activity
There is no recent news or activity for this profile.